Erratum to the importance of PD-L1 diagnostic assay harmonization for the selection of lung cancer immunotherapy
Erratum

Erratum to the importance of PD-L1 diagnostic assay harmonization for the selection of lung cancer immunotherapy

doi: 10.21037/jtd.2019.01.85


Erratum to: J Thorac Dis 2018;10:S4096-100


The importance of PD-L1 diagnostic assay harmonization for the selection of lung cancer immunotherapy

In the article that appeared on Page S4096-S4100, Vol 10, Suppl 33 (November 2018) Issue of the Journal of Thoracic Disease (JTD) (1), One of the author’s last name was misspelled as “Zatarain-Brrón”. It should read as “Zatarain-Barrón”.

The publisher regrets the error.


References

  1. Hernandez-Martinez JM, Zatarain-Barrón ZL, Cardona AF, et al. The importance of PD-L1 diagnostic assay harmonization for the selection of lung cancer immunotherapy. J Thorac Dis 2018;10:S4096-100. [Crossref] [PubMed]
Cite this article as: Erratum to the importance of PD-L1 diagnostic assay harmonization for the selection of lung cancer immunotherapy. J Thorac Dis 2019;11(3):E64. doi: 10.21037/jtd.2019.01.85